NOVO NORDISK A S

13D and 13G Filings

Issuer	CUSIP	% of Class	Shares	Form	Filed
Innate Pharma SA 13G/A Amendment 4 45781K105	45781K105	0%	0	13G/A Amendment 4	6/22/2026 Event 5/29/2026
Innate Pharma SA 13G/A Amendment 3 45781K105	45781K105	5.0%	4,718,727	13G/A Amendment 3	4/10/2026 Event 3/31/2026
Innate Pharma SA 13G/A Amendment 2 45781K105	45781K105	7.8%	7,333,778	13G/A Amendment 2	3/4/2026 Event 12/31/2025
Innate Pharma SA 13G/A Amendment 1 45781K105	45781K105	9.7%	8,895,649	13G/A Amendment 1	10/21/2025 Event 7/14/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.